| |
|
|
|
|
|
|
|||
|
Blood, Vol. 95 No. 7 (April 1), 2000:
pp. 2204-2210
PLENARY PAPER
From the Department of Hematopoietic Factors, the Institute of
Medical Science, the University of Tokyo, Tokyo, Japan; the Department
of Immunology, Tokai University School of Medicine, Isehara, Japan;
Mammalian Genetics Laboratory, Advanced Bioscience Laboratories
(ABL)-Basic Research Program, National Cancer Institute-Frederick
Cancer Research and Development Center, Frederick, MD; and the
Department of Allergy and Rheumatology, Graduate School of Medicine,
the University of Tokyo, Tokyo, Japan.
In a complementary DNA (cDNA) screening of murine Th2-skewed
lymphocytes with our recently developed signal sequence trap method
termed SST-REX, a novel type 1 cytokine receptor, Delta1 (
Cytokine systems regulate cellular growth and
differentiation in hematopoiesis, immune systems, tissue development,
and morphogenesis.1,2 Identification of novel members of
the cytokine family and their receptors is of great importance because
they play key roles in regulating a broad-range biological response.
Cytokines have a highly conserved 4-helix bundle tertiary structure but
have a low homology in the primary amino acid
sequence.3 Therefore, identification of novel cytokines
using homology-based cloning methods has been rather difficult.
Cytokine signals are mediated through specific receptor complexes,
including type 1 and type 2 cytokine receptors, the tumor necrosis
factor receptor superfamily, the tumor growth factor
receptor superfamily, and tyrosine kinase receptors.4-8 The
type 1 cytokine receptors transmit signals of the group of cytokines
involved in hematopoiesis and blood cell functions, and they are also
known as the hemopoietin receptor family. Members of the type 1 cytokine receptor family are readily identified by a cytokine
receptor module comprising 2 fibronectin type III-like domains
containing the N-terminal domain with conserved cysteine residues and
by the highly conserved Trp-Ser-X-Trp-Ser (WSXWS) sequence present
above the transmembrane domain.9-12 Structural alterations
of these receptors occur in tumorigenesis,13
immunodeficiency,14 genetic susceptibility to some
pathologic conditions such as allergic sensitivity,15,16
and metabolic disorders such as alveolar proteinosis.17
Therefore, the molecular cloning of a novel cytokine receptor may help
to understand the pathogenesis of some disease and to tailor
treatments accordingly. Most members of the type 1 cytokine receptor family have been cloned using ligand binding as an
assay. Alternatively, oligonucleotides for the WSXWS
motif were used as hybridization probes, and degenerate polymerase
chain reaction (PCR) with primers for the highly conserved region of type 1 cytokine receptors was also used. Nowadays, some cytokine receptors can be identified in a search of expressed sequence tag (EST)
database as a result of homology with known cytokine receptors.18,19
We developed a method termed SST-REX (signal sequence trap by
retrovirus-mediated expression screening)20 that detects
signal sequences in complementary DNA (cDNA) fragments based on their ability to redirect a constitutively active mutant of a cytokine receptor21 to the cell surface, thereby allowing
interleukin-3 (IL-3)-independent growth of otherwise IL-3-dependent
Ba/F3 cells.20 SST-REX is an improved version of the signal
sequence trap methods originally described by Tashiro et
al22 and modified by Klein et al23 by which
cDNAs for secreted molecules and surface proteins are selectively
isolated. We now report isolation and characterization of a novel type
1 cytokine receptor, Delta 1 ( Reagents
Cell lines and cell culture
Construction of the cDNA library for SST-REX Induction of antigen-specific activation of Th1/Th2 cells was performed using DO11.10 transgenic mice as described,30 and poly(A)+ RNA samples were prepared from resting or activated Th1 and Th2 cells using FastTrack2.0 Kit (Invitrogen Carlsbad, CA). Complementary DNA (cDNA) was synthesized from poly(A)+ RNA of resting Th1 and Th2 cells with random hexamers using SuperScript Choice System (Gibco-BRL, Rockville, MD) according to the manufacturer's instructions. The synthesized cDNA was size-separated through SizeSep 400 Spun Column (Pharmacia, Uppsala, Sweden) and inserted into BstXI sites of pMX-SST using BstXI adaptors (Invitrogen). The ligated DNA was electroporated into DH10B cells (Electromax, Gibco-BRL) using an E-coli Pulser (Bio-Rad, Hercules, CA) at 1.8 kV. Plasmid DNA was prepared using JETstar (Genomed, Research Triangle Park, NC) from 200-ml Escherichia coli culture. Infection of Ba/F3 cells with high-titer retroviruses derived from the library for SST and, also, isolation of cDNA fragments by PCR from factor-independent clones were performed as described. 20Construction of a cDNA library from resting Th2 cells Complementary DNA was synthesized from poly(A)+ RNA from resting Th2 cells with oligo-dT primers, using SuperScript Choice System, as described above, and inserted into BstXI sites of pME18S,31 using BstXI adaptors. The ligated DNA was electroporated, and plasmid DNA was prepared as described above.Cloning of 1 cDNA with oligoprimers 5'GGTGATGTCACAGTCGTCTGCCATG3' and 5' TGCCAGGCGTCCTCATCGTCATT3' using 50-µM
Biotin-21-dUTP (Clontech Laboratories, Palo Alto, CA), 200-µM dATP,
200-µM dGTP, 200-µM dCTP, and 10-µM dTTP. An
oligo-dT-primed cDNA library of resting Th2 cells was screened using
RecA protein coated with biotinylated linear DNA probes as
described.32-34
Northern blot analysis A Mouse Multiple Tissue Northern Blot (Clontech) was probed with the 407-bp 1-specific PCR fragments generated with the same set of
primers as described above. The blots were hybridized overnight in 50%
formamide, 5 × SSC, 1% sodium dodecyl sulfate (SDS),
6 × Denhardt's reagent, and 100 µg/ml of salmon sperm DNA at
42°C with a 32P-labeled randomly primed
probe and washed at 55°C in 0.1 × SSC and 0.1%
SDS, followed by exposure to radiographic film. Poly(A)+ RNA samples (3 µg) prepared from various mouse cell lines using FastTrack2.0 Kit
were separated by electrophoresis through a 1% agarose formaldehyde
gel and transferred to Hybond-N+ (Amersham, Arlington Heights, IL)
nylon filter. The Northern blot was hybridized and washed as described above.
Construction and expression of chimeric receptors consisting of the
human receptor for EPO or TPO and 1R and hMPL- 1R, an EcoRI site
was inserted between the extracellular and transmembrane domains of
each cDNA. Then, the cytoplasmic domain of 1 cDNA generated by PCR
with high-fidelity DNA polymerase Pyrobest (Takara Otsu, Shiga,
Japan) was cloned into pMX-puro at 5'-EcoRI
and 3'-NotI sites, and the EcoRI fragment containing the extracellular domain of hEPOR or hMPL37 was
cloned into a 5'-EcoRI site). The primers used to create
EcoRI and NotI sites in the 1 cDNA were
5'-AAAGAATTCCCGCCCCTCCTGCCCCTGGGC-3' and
5'-GCTGGCGGCCGCACCTGCAGGCGC-3'. The primers used to create EcoRI sites in hEPOR cDNA were
5'-AAAGAATTCGGGGGCTGTATCATGGAC-3' and
5'-AAAGAATTCGGGGTCCAGGTCGCTAGG-3'. The primers used to
create EcoRI sites in hMPL cDNA were
5'-GGTAGGGAATTCCGGAATTTCCTCGAGATG-3' and
5'-AAAGAATTCCCAGGCGGTCTCGGTGGCGGT-3'. To construct a
chimeric receptor EDER, a 57-amino acid stretch covering the
transmembrane domain and the box1 region of hEPOR was replaced with the
corresponding region of 1; first, an HpaI site was inserted
between the extracellular and transmembrane domains, and an
XhoI site was inserted downstream of the conserved tryptophan
residue in the cytoplasmic domain of hEPOR. Second, the box1 region of
1 cDNA was cloned into the EcoRI and NotI sites of
the pMX-puro. Then, the cytoplasmic region of hEPOR was cloned into the
XhoI and NotI sites, and the extracellular domain of
hEPOR was cloned into the EcoRI and HpaI sites. The primers used to create 5'-EcoRI and HpaI sites
and 3'-XhoI and NotI sites at the end of the 1
cDNA spanning the transmembrane and the membrane-proximal region were
5'-AAAGAATTCGTTAACCCGCCCCTCCTGCCCCTGGGG-3' and
5'-AAAGCGGCCGCCTCGAGCCAGGCCTGGAAGTTCCC-3'. The primers used to create 5'-XhoI and 3'-NotI sites in the
cytoplasmic region of hEPOR were
5'-AAACTCGAGCTGTACCAGAATGATGGC-3' and
5'-AAAGCGGCCGCTCACTTGTCGTCATCGTCCTTGTAATCAGAG- CAAGCCACATAGCT-3'.
The primers used to create 5'-EcoRI and
3'-HpaI sites in the extracellular region of hEPOR were
5'-AAAGAATTCGGGGGCTGTATCATGGAC-3' and
5'-AAAGTTAACGGGGTCCAGGTCGCTAGG-3'. All constructs were
confirmed by restriction enzyme analyses and sequencing.
Construction and expression of a tagged molecule of 1, 1-FLAG was designed by fusing the
FLAG-sequence (DYKDDDDK) to the C-terminus of 1. A PCR fragment of
the 1-FLAG was cloned into pMX-puro retrovirus vector at
5'-EcoRI and 3'-NotI sites. The primers
used to add the FLAG sequence to the C-terminus of 1 was
5'-AGGGAATTCCGGAATTTCCTCGAGATC-3' and 5'-AAAGCGGCCGCTCACTTGTCGTCATCGTCCTTGTAATCC- AGGGTCATGTAGCCGCTGTC-3'.
Immunoprecipitation and Western blotting Cells were lysed in the lysis buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1% Triton X-100; 1 mM EDTA; 0.2 mM Na3VO4; and 2 mM PMSF). For surface labeling of the cells, NHS-LC-Biotin (Pierce, Rockford, IL) was added prior to cell lysis. Lysates were cleared of debris by centrifugation at 12 000g for 40 minutes, and the supernatants were incubated with antibodies at 4°C for 2 hours. Immune complexes were precipitated with protein A-Sepharose (Pharmacia), washed with the lysis buffer, and proteins were eluted with the sample buffer (62.5 mM Tris-HCl, pH 6.8; 2% SDS; 10% glycerol; 5% 2-mercaptoethanol; and 0.02% bromophenol blue) for SDS-PAGE (SDS-polyacrylamide gel electrophoresis). The eluted proteins were electrophoresed on an 8%-to-16% gradient gel (Gradipore, North Ryde, Australia). Membranes were probed with antibodies or streptavidin-horseradish peroxidase (Vector Laboratories, Burlingame, CA) and visualized using the enhanced chemiluminescence detection system (Amersham) as described by the manufacturer.Chromosomal localization Interspecific backcross progenies were generated by mating (C57BL/6J × Mus spretus) F1 females and C57BL/6J males.39 A total of 205 N2 mice were used to map the 1 locus. DNA isolation,
restriction enzyme digestion, agarose gel electrophoresis, Southern
blot transfer, and hybridization were performed essentially as
described.40 All blots were prepared with Hybond-N+ nylon
membrane (Amersham). The probe, a 407-bp fragment of mouse cDNA, was
labeled with [ 32P] dCTP using a random primed labeling
kit (Stratagene, La Jolla, CA); washing was done to a final stringency
of 1.0 × standard saline citrate (SSC), 0.1% SDS,
65°C. C57BL/6J and M. spretus DNAs were
digested with several enzymes and analyzed by Southern blot
hybridization for informative restriction fragment length polymorphisms
(RFLPs) using a mouse cDNA 1 probe. An ScaI fragment of 8.7 kilobases (kb) or 11.0 kb was detected in C57BL/6J DNA or M. spretus DNA, respectively. The presence or absence of 11.0-kb ScaI M. spretus-specific fragment was followed in
backcross mice.
Isolation and sequencing of the receptor ( c)43
at the amino acid level. A full-length cDNA was obtained from an
oligo-dT-primed cDNA library derived from resting Th2 cells using the
RecA screening system32-34 and was confirmed to contain a
sequence that was identical to f215 (Figure
1A).
Expression of
Functional analysis of Phosphorylation of Janus kinases by the EDE chimeric receptor The mitogenic activity of the EDER suggested that JAK was activated by hEPO-induced dimerization. Indeed, Western blot analysis detected hEPO-dependent JAK2 phosphorylation in cells expressing the EDER (Figure 5). JAK1, JAK3, and TYK2 were not phosphorylated in response to hEPO stimulation in the cells expressing the EDER. None of the 4 JAKs were phosphorylated in response to EPO or TPO stimulation in cells expressing a chimeric receptor hEPO- 1R or hMPL- 1R, respectively (data not shown).
Expression of 1-FLAG, was designed to express
a tagged molecule of 1 and was introduced into Ba/F3 cells via
retrovirus infection. The cell lysate was immunoprecipitated by the
anti-FLAG antibody (Figure 6). The
expressed 1 protein had a molecular mass of 50 kd, which is larger
than the calculated molecular mass of 37 791 d. The difference is
probably due to attachment of sugar moieties to some of the 2 predicted
potential N-linked glycosylation sites found in the extracellular
domain of 1.
Chromosomal mapping of the 1 was determined by
interspecific backcross analysis using progeny derived from matings of
([C57BL/6J x M. spretus] F1 x C57BL/6J) mice. This
interspecific backcross mapping panel has been typed for more than 2900 loci that are well distributed among all the autosomes as well as the X
chromosome.39 The 11.0-kb ScaI M. spretus
RFLP (see "Materials and methods") was used to follow
segregation of the 1 locus in backcross mice. The mapping results
indicated that 1 is located in the central region of mouse
chromosome 5 linked to Fgf5, Dmp1, Gfi1, and Crybb2. Although 106 mice
were analyzed for every marker and are shown in the segregation
analysis (Figure 7), up to 154 mice were
typed for some pairs of markers. Each locus was analyzed in pairwise
combinations for recombination frequencies using the additional data.
The ratios of the total number of mice exhibiting recombinant
chromosomes to the total number of mice analyzed for each pair of loci
and the most likely gene order are as follows: centromere Fgf5-4/151
Dmp1-0/136 1-0/154 Gfi1-4/145 Crybb2. The recombination
frequencies [expressed as genetic distances in centiMorgans (cM) ± the standard error] are: centromere Fgf5-2.7 ± 1.3 [Dmp1, 1, Gfi1] 2.8 ± 1.4 Crybb2. No recombinants were detected between Dmp1 and 1 in 136 or
between 1 and Gfi1 in 154 mice typed in common, suggesting
that 2 loci in each pair are within 2.2 and 1.9 cM of each other,
respectively (upper 95% confidence limit).
We isolated and characterized a novel member of the type 1 cytokine receptor family,
We thank M. Ohara for critical reading of the manuscript and Dr S. Asano for continuous encouragement.
Submitted October 12, 1999; accepted December 10, 1999.
Supported in part by Chugai Pharmaceutical Company Ltd and grants from the Ministry of Education, Science, Sports, and Culture of Japan.
The nucleotide sequence data for this cDNA will appear in the DNA Databank of Japan/European Molecular Biology Laboratory/Genbank nucleotide sequence database with accession number AB031333.
Reprints: Toshio Kitamura, Department of Hematopoietic Factors, the Institute of Medical Science, the University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan; e-mail: kitamura{at}ims.u-tokyo.ac.jp.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
1. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783[Medline] [Order article via Infotrieve]. 2. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241[Medline] [Order article via Infotrieve]. 3. Rozwarski DA, Gronenborn AM, Clore GM, et al. Structural comparisons among the short-chain helical cytokines. Structure. 1994;2:159[Medline] [Order article via Infotrieve]. 4. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol. 1992;10:295[Medline] [Order article via Infotrieve].
5.
Kaushansky K, Karplus PA.
Hematopoietic growth factors: understanding functional diversity in structural terms.
Blood.
1993;82:3229 6. Stahl N, Yancopoulos GD. The alphas, betas, and kinases of cytokine receptor complexes. Cell. 1993;74:587[Medline] [Order article via Infotrieve]. 7. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell. 1994;76:253[Medline] [Order article via Infotrieve]. 8. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331[Medline] [Order article via Infotrieve]. 9. Bazan JF. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin, and IL-6 receptors, and the p75 IL-2 receptor b chain. Biochem Biophys Res Commum. 1989;164:788[Medline] [Order article via Infotrieve]. 10. D'Andrea AD, Fasman GD, Lordish HF. Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family. Cell. 1989;58:1023[Medline] [Order article via Infotrieve].
11.
Bazan JF.
Structural design and molecular evolution of a cytokine receptor superfamily.
Proc Natl Acad Sci U S A.
1990;87:6934 12. Cosman D, Lyman SD, Idzerda RL, et al. A new cytokine receptor superfamily. Trends Biochem Sci. 1990;15:265[Medline] [Order article via Infotrieve].
13.
Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP.
Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia [see comments].
N Engl J Med.
1995;333:487 14. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147[Medline] [Order article via Infotrieve].
15.
Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA.
The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor [see comments].
N Engl J Med.
1997;337:1720 16. Mitsuyasu H, Izuhara K, Mao XQ, et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma [letter]. Nat Genet. 1998;19:119[Medline] [Order article via Infotrieve].
17.
Dirksen U, Hattenhorst U, Schneider P, et al.
Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure.
Blood.
1998;92:1097 18. Sprecher CA, Grant FJ, Baumgartner JW, et al. Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun. 1998;246:82[Medline] [Order article via Infotrieve].
19.
Elson GC, Graber P, Losberger C, et al.
Cytokine-like factor-1, a novel soluble protein, shares homology with members of the cytokine type 1 receptor family.
J Immunol.
1998;161:1371 20. Kojima T, Kitamura T. A novel signal sequence trap method using retrovirus-mediated gene transfer. Nat Biotechnol. 1999;17:487[Medline] [Order article via Infotrieve].
21.
Onishi M, Mui ALF, Morikawa Y, et al.
Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.
Blood.
1996;88:1399
22.
Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T.
Signal sequence trap: a cloning strategy for secreted proteins and type 1 membrane proteins.
Science.
1993;261:600
23.
Klein RD, Gu Q, Goddard A, Rosenthal A.
Selection for genes encoding secreted proteins and receptors.
Proc Natl Acad Sci U S A.
1996;93:7108 24. Palacios R, Steinmetz M. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 1985;41:727[Medline] [Order article via Infotrieve].
25.
Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D.
Growth of factor dependent haemopoietic cell lines.
J Exp Med.
1980;152:1036
26.
Lee KH, Kinashi T, Tohyama K, et al.
Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.
J Exp Med.
1991;173:1257
27.
Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ.
Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell line.
Proc Natl Acad Sci U S A.
1983;80:2931 28. Cerottini J-C, Engers HD, MacDonald HR, Brunner KT. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med. 1974;140:703[Abstract].
29.
Pear WS, Nolan GP, Scott ML, Baltimore D.
Production of high-titer helper-free retroviruses by transient transfection.
Proc Natl Acad Sci U S A.
1993;90:8392 30. Ohta A, Sato N, Yahata T, et al. Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen- specific Th1 or Th2 cells. J Immunol Methods. 1997;209:85[Medline] [Order article via Infotrieve].
31.
Kitamura T, Hayashida K, Sakamaki K, Yokota T, Arai K, Miyajima A.
Reconstitution of functional human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that AIC2B is a subunit of murine GM-CSF receptor.
Proc Natl Acad Sci U S A.
1991;88:5082
32.
Honigberg SM, Rao BJ, Radding CM.
Ability of RecA protein to promote a search for rare sequences in duplex DNA.
Proc Natl Acad Sci U S A.
1986;83:9586
33.
Rigas B, Welcher AA, Ward DC, Weissman SM.
Rapid plasmid library screening using RecA-coated biotinylated probes.
Proc Natl Acad Sci U S A.
1986;83:9591 34. Teintze M, Arzimanoglou II, Lovelace CI, Xu ZJ, Rigas B. RecA-assisted rapid enrichment of specific clones from model DNA libraries. Biochem Biophys Res Commun. 1995;211:804[Medline] [Order article via Infotrieve].
35.
Noguchi CT, Bae KS, Chin K, Wada Y, Schechter AN, Hankins WD.
Cloning of the human erythropoietin receptor gene.
Blood.
1991;78:2548
36.
Onishi M, Nosaka T, Misawa K, et al.
Identification and characterization of a constitutive active STAT5 mutant that promotes cell proliferation.
Mol Cell Biol.
1998;18:3871
37.
Vigon I, Mornon JP, Cocault L, et al.
Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.
Proc Natl Acad Sci U S A.
1992;89:5640
38.
Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A, Nolan GP.
Efficient screening of retroviral cDNA expression libraries.
Proc Natl Acad Sci U S A.
1995;92:9146 39. Copeland NG, Jenkins NA. Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet. 1991;7:113[Medline] [Order article via Infotrieve].
40.
Jenkins NA, Copeland NG, Taylor BA, Lee BK.
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus.
J Virol.
1982;43:26 41. Liao X, Buchberg AM, Jenkins NA, Copeland NG. Evi-5, a common site of retroviral integration in AKXD T-cell lymphomas, maps near Gfi-1 on mouse chromosome 5. J Virol. 1995;69:7132[Abstract].
42.
George A, Bannon L, Sabsay B, et al.
The carboxyl-terminal domain of phosphophoryn contains unique extended triplet amino acid repeat sequences forming ordered carboxyl-phosphate interaction ridges that may be essential in the biomineralization process.
J Biol Chem.
1996;271:32,869 43. Kobayashi N, Nakagawa S, Minami Y, Taniguchi T, Kono T. Cloning and sequencing of the cDNA encoding a mouse IL-2 receptor gamma. Gene. 1993;130:303[Medline] [Order article via Infotrieve].
44.
Murakami M, Narazaki M, Hibi M, et al.
Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.
Proc Natl Acad Sci U S A.
1991;88:11,349
45.
Miura O, Cleveland JL, Ihle JN.
Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors.
Mol Cell Biol.
1993;13:1788
46.
Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS.
The conserved box 1 motif of cytokine receptors is required for association with JAK kinases.
J Biol Chem.
1995;270:6523
47.
Goldsmith MA, Xu W, Amaral MC, Kuczek ES, Greene WC.
The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements.
J Biol Chem.
1994;269:14,698
48.
He TC, Jiang N, Zhuang H, Quelle DE, Wojchowski DM.
The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells.
J Biol Chem.
1994;269:18,291
49.
Quelle FW, Sato N, Witthuhn BA, et al.
JAK2 associates with the beta c chain of the receptor for granulocyte- macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.
Mol Cell Biol.
1994;14:4335
50.
Behrmann I, Janzen C, Gerhartz C, et al.
A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation.
J Biol Chem.
1997;272:5269
51.
Pless M, Norga K, Carroll M, Heim MH, D'Andrea AD, Mathey-Prevot B.
Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding.
Blood.
1997;89:3175 52. Ferrag F, Pezet A, Chiarenza A, et al. Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathways. FEBS Lett 1998;421:32[Medline] [Order article via Infotrieve]. 53. Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993;74:227[Medline] [Order article via Infotrieve].
54.
Jiang N, He TC, Miyajima A, Wojchowski DM.
The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera.
J Biol Chem.
1996;271:16,472
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
L. J. Russell, M. Capasso, I. Vater, T. Akasaka, O. A. Bernard, M. J. Calasanz, T. Chandrasekaran, E. Chapiro, S. Gesk, M. Griffiths, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia Blood, September 24, 2009; 114(13): 2688 - 2698. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Liu Thymic stromal lymphopoietin: master switch for allergic inflammation J. Exp. Med., February 21, 2006; 203(2): 269 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Carpino, W. E. Thierfelder, M.-s. Chang, C. Saris, S. J. Turner, S. F. Ziegler, and J. N. Ihle Absence of an Essential Role for Thymic Stromal Lymphopoietin Receptor in Murine B-Cell Development Mol. Cell. Biol., March 15, 2004; 24(6): 2584 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ozaki and W. J. Leonard Cytokine and Cytokine Receptor Pleiotropy and Redundancy J. Biol. Chem., August 9, 2002; 277(33): 29355 - 29358. [Full Text] [PDF] |
||||
![]() |
N. Shah, L. Oseth, H. Tran, B. Hirsch, and T. W. LeBien Clonal Variation in the B-Lineage Acute Lymphoblastic Leukemia Response to Multiple Cytokines and Bone Marrow Stromal Cells Cancer Res., July 1, 2001; 61(13): 5268 - 5274. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Reche, V. Soumelis, D. M. Gorman, T. Clifford, M.-r. Liu, M. Travis, S. M. Zurawski, J. Johnston, Y.-J. Liu, H. Spits, et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells J. Immunol., July 1, 2001; 167(1): 336 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chklovskaia, C. Nissen, L. Landmann, C. Rahner, O. Pfister, and A. Wodnar-Filipowicz Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor {gamma}-chain signaling and inhibited by cyclosporin A Blood, February 15, 2001; 97(4): 1027 - 1034. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2000 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||